Europe Nucleic Acid Isolation and Purification Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Method (Magnetic Beads, Column Based, Reagent Based), By Type , By End User, By Country and Growth Forecast, 2023 - 2030
Description
Europe Nucleic Acid Isolation and Purification Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Method (Magnetic Beads, Column Based, Reagent Based), By Type , By End User, By Country and Growth Forecast, 2023 - 2030
The Europe Nucleic Acid Isolation and Purification Market would witness market growth of 8.8% CAGR during the forecast period (2023-2030).
There is an increasing demand for point-of-care testing, driving the development of portable and rapid nucleic acid isolation devices that can be used in decentralized settings such as clinics, remote locations, or even directly at the patient's side. These advancements enable quicker and more immediate diagnostic decisions, particularly in emergency situations or resource-limited environments. Point-of-care nucleic acid extraction devices are instrumental in expediting the diagnostic process and improving patient outcomes.
There is a growing focus on developing specialized extraction kits tailored for specific sample types or applications. These kits are optimized to extract nucleic acids from diverse sources efficiently. Tailored kits enhance the efficiency and accuracy of nucleic acid isolation for specific purposes, whether it's environmental samples, clinical specimens, forensic materials, or agricultural sources. This trend ensures that the extraction process is optimized for varying sample types, leading to higher quality and better outcomes in downstream applications.
Europe is experiencing demographic changes, with a growing proportion of elderly citizens. This demographic shift leads to increased healthcare expenditure due to higher utilization of healthcare services. For example, countries like Germany and Italy have a substantial percentage of their populations aged 65 and older, resulting in higher healthcare costs associated with age-related conditions and long-term care. Therefore, rising investments in healthcare facilities in Europe is expected to drive the growth of the market in the future.
The Germany market dominated the Europe Nucleic Acid Isolation and Purification Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $715.9 million by 2030. The UK market is exhibiting a CAGR of 7.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.6% during (2023 - 2030).
Based on Application, the market is segmented into Diagnostics, Drug Discovery & Development, Agriculture & Animal Research, and Personalized Medicine & Others. Based on Product, the market is segmented into Reagents, Kits, and Instruments. Based on Method, the market is segmented into Magnetic Beads, Column Based, Reagent Based, and Others. Based on Type, the market is segmented into Plasmid DNA Isolation & Purification, Total RNA Isolation & Purification, Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, microRNA Isolation & Purification, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.
Scope of the Study
Market Segments covered in the Report:
By Application
- Diagnostics
- Drug Discovery & Development
- Agriculture & Animal Research
- Personalized Medicine & Others
- Reagents
- Kits
- Instruments
- Magnetic Beads
- Column Based
- Reagent Based
- Others
- Plasmid DNA Isolation & Purification
- Total RNA Isolation & Purification
- Circulating Nucleic Acid Isolation & Purification
- Genomic DNA Isolation & Purification
- Messenger RNA Isolation & Purification
- microRNA Isolation & Purification
- Others
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- F. Hoffmann-La Roche Ltd.
- Merck KGaA
- Promega Corporation
- Agilent Technologies, Inc.
- Danaher Corporation
- Bio-Rad laboratories, Inc.
- Illumina, Inc.
- New England Biolabs, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
182 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Nucleic Acid Isolation and Purification Market, by Application
- 1.4.2 Europe Nucleic Acid Isolation and Purification Market, by Product
- 1.4.3 Europe Nucleic Acid Isolation and Purification Market, by Method
- 1.4.4 Europe Nucleic Acid Isolation and Purification Market, by Type
- 1.4.5 Europe Nucleic Acid Isolation and Purification Market, by End User
- 1.4.6 Europe Nucleic Acid Isolation and Purification Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market At a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2022
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar – 2023, Oct) Leading Players
- 4.5 Porter’s Five Forces Analysis
- Chapter 5. Europe Nucleic Acid Isolation and Purification Market by Application
- 5.1 Europe Diagnostics Market by Country
- 5.2 Europe Drug Discovery & Development Market by Country
- 5.3 Europe Agriculture & Animal Research Market by Country
- 5.4 Europe Personalized Medicine & Others Market by Country
- Chapter 6. Europe Nucleic Acid Isolation and Purification Market by Product
- 6.1 Europe Reagents Market by Country
- 6.2 Europe Kits Market by Country
- 6.3 Europe Instruments Market by Country
- Chapter 7. Europe Nucleic Acid Isolation and Purification Market by Method
- 7.1 Europe Magnetic Beads Market by Country
- 7.2 Europe Column Based Market by Country
- 7.3 Europe Reagent Based Market by Country
- 7.4 Europe Others Market by Country
- Chapter 8. Europe Nucleic Acid Isolation and Purification Market by Type
- 8.1 Europe Plasmid DNA Isolation & Purification Market by Country
- 8.2 Europe Total RNA Isolation & Purification Market by Country
- 8.3 Europe Circulating Nucleic Acid Isolation & Purification Market by Country
- 8.4 Europe Genomic DNA Isolation & Purification Market by Country
- 8.5 Europe Messenger RNA Isolation & Purification Market by Country
- 8.6 Europe microRNA Isolation & Purification Market by Country
- 8.7 Europe Others Market by Country
- Chapter 9. Europe Nucleic Acid Isolation and Purification Market by End User
- 9.1 Europe Hospitals & Diagnostic Centers Market by Country
- 9.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
- 9.3 Europe Academic Research Institutes Market by Country
- 9.4 Europe Contract Research Organizations Market by Country
- 9.5 Europe Others Market by Country
- Chapter 10. Europe Nucleic Acid Isolation and Purification Market by Country
- 10.1 Germany Nucleic Acid Isolation and Purification Market
- 10.1.1 Germany Nucleic Acid Isolation and Purification Market by Application
- 10.1.2 Germany Nucleic Acid Isolation and Purification Market by Product
- 10.1.3 Germany Nucleic Acid Isolation and Purification Market by Method
- 10.1.4 Germany Nucleic Acid Isolation and Purification Market by Type
- 10.1.5 Germany Nucleic Acid Isolation and Purification Market by End User
- 10.2 UK Nucleic Acid Isolation and Purification Market
- 10.2.1 UK Nucleic Acid Isolation and Purification Market by Application
- 10.2.2 UK Nucleic Acid Isolation and Purification Market by Product
- 10.2.3 UK Nucleic Acid Isolation and Purification Market by Method
- 10.2.4 UK Nucleic Acid Isolation and Purification Market by Type
- 10.2.5 UK Nucleic Acid Isolation and Purification Market by End User
- 10.3 France Nucleic Acid Isolation and Purification Market
- 10.3.1 France Nucleic Acid Isolation and Purification Market by Application
- 10.3.2 France Nucleic Acid Isolation and Purification Market by Product
- 10.3.3 France Nucleic Acid Isolation and Purification Market by Method
- 10.3.4 France Nucleic Acid Isolation and Purification Market by Type
- 10.3.5 France Nucleic Acid Isolation and Purification Market by End User
- 10.4 Russia Nucleic Acid Isolation and Purification Market
- 10.4.1 Russia Nucleic Acid Isolation and Purification Market by Application
- 10.4.2 Russia Nucleic Acid Isolation and Purification Market by Product
- 10.4.3 Russia Nucleic Acid Isolation and Purification Market by Method
- 10.4.4 Russia Nucleic Acid Isolation and Purification Market by Type
- 10.4.5 Russia Nucleic Acid Isolation and Purification Market by End User
- 10.5 Spain Nucleic Acid Isolation and Purification Market
- 10.5.1 Spain Nucleic Acid Isolation and Purification Market by Application
- 10.5.2 Spain Nucleic Acid Isolation and Purification Market by Product
- 10.5.3 Spain Nucleic Acid Isolation and Purification Market by Method
- 10.5.4 Spain Nucleic Acid Isolation and Purification Market by Type
- 10.5.5 Spain Nucleic Acid Isolation and Purification Market by End User
- 10.6 Italy Nucleic Acid Isolation and Purification Market
- 10.6.1 Italy Nucleic Acid Isolation and Purification Market by Application
- 10.6.2 Italy Nucleic Acid Isolation and Purification Market by Product
- 10.6.3 Italy Nucleic Acid Isolation and Purification Market by Method
- 10.6.4 Italy Nucleic Acid Isolation and Purification Market by Type
- 10.6.5 Italy Nucleic Acid Isolation and Purification Market by End User
- 10.7 Rest of Europe Nucleic Acid Isolation and Purification Market
- 10.7.1 Rest of Europe Nucleic Acid Isolation and Purification Market by Application
- 10.7.2 Rest of Europe Nucleic Acid Isolation and Purification Market by Product
- 10.7.3 Rest of Europe Nucleic Acid Isolation and Purification Market by Method
- 10.7.4 Rest of Europe Nucleic Acid Isolation and Purification Market by Type
- 10.7.5 Rest of Europe Nucleic Acid Isolation and Purification Market by End User
- Chapter 11. Company Profiles
- 11.1 Thermo Fisher Scientific, Inc.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Segmental and Regional Analysis
- 11.1.4 Research & Development Expenses
- 11.1.5 Recent strategies and developments:
- 11.1.5.1 Partnerships, Collaborations, and Agreements:
- 11.1.5.2 Product Launches and Product Expansions:
- 11.1.6 SWOT Analysis
- 11.2 Qiagen N.V.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expense
- 11.2.5 Recent strategies and developments:
- 11.2.5.1 Product Launches and Product Expansions:
- 11.2.5.2 Acquisition and Mergers:
- 11.2.5.3 Geographical Expansions:
- 11.2.6 SWOT Analysis
- 11.3 F. Hoffmann-La Roche Ltd.
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental and Regional Analysis
- 11.3.4 Research & Development Expense
- 11.3.5 Recent strategies and developments:
- 11.3.5.1 Partnerships, Collaborations, and Agreements:
- 11.3.5.2 Product Launches and Product Expansions:
- 11.3.6 SWOT Analysis
- 11.4 Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Segmental and Regional Analysis
- 11.4.4 Research & Development Expense
- 11.4.5 SWOT Analysis
- 11.5 Promega Corporation
- 11.5.1 Company Overview
- 11.5.2 Recent strategies and developments:
- 11.5.2.1 Partnerships, Collaborations, and Agreements:
- 11.5.2.2 Product Launches and Product Expansions:
- 11.5.3 SWOT Analysis
- 11.6 Agilent Technologies, Inc.
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Segmental and Regional Analysis
- 11.6.4 Research & Development Expense
- 11.6.5 SWOT Analysis
- 11.7 Danaher Corporation
- 11.7.1 Company Overview
- 11.7.2 Financial Analysis
- 11.7.3 Segmental and Regional Analysis
- 11.7.4 Research & Development Expense
- 11.7.5 SWOT Analysis
- 11.8 Bio-Rad laboratories, Inc.
- 11.8.1 Company Overview
- 11.8.2 Financial Analysis
- 11.8.3 Segmental and Regional Analysis
- 11.8.4 Research & Development Expenses
- 11.8.5 Recent strategies and developments:
- 11.8.5.1 Product Launches and Product Expansions:
- 11.8.5.2 Acquisition and Mergers:
- 11.8.6 SWOT Analysis
- 11.9 Illumina, Inc.
- 11.9.1 Company Overview
- 11.9.2 Financial Analysis
- 11.9.3 Regional Analysis
- 11.9.4 Research & Development Expense
- 11.9.5 SWOT Analysis
- 11.10. New England Biolabs, Inc.
- 11.10.1 Company Overview
- 11.10.2 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


